Bioavailability and Safety of Two Oral Fixed Dose Preparations Containing 18 mg Ivermectin (IVM 18 MG TABLETS, LICONSA S.A., Spain) Versus Reference Dosing (Weight Based) Containing 6 mg Ivermectin (REVECTINA®, Abbott Laboratórios do Brasil Ltda, Brazil)

Helminthiasis

Tuberculosis – Learning the Effect of Parasites and Reinforcing Diets Activation and Function of Eosinophils in Conditions With Blood or Tissue Eosinophilia Impact of Alternative Treatment Strategies and Delivery Systems for Soil-transmitted Helminths in Kenya Design and Clinical Evaluation of a School Meal With Deworming Properties Taenia Solium Control Case Study in Zambia Spillover Effects of Water, Sanitation, and Hygiene Interventions on Child Health Efficacy of Albendazole to Treat Intestinal Helminths and Its Effect on Gut Microflora The Longevity of Trichuris Trichiura Colonization Treatment of Helminth co-Infection: Short-Term Effects on HIV-1 Progression Markers and Immune Activation Albendazole Plus High Dose Ivermectin for Trichuriasis in Pediatric Patients Bioavailability and Safety of Two Oral Fixed Dose Preparations Containing 18 mg Ivermectin (IVM 18 MG TABLETS, LICONSA S.A., Spain) Versus Reference Dosing (Weight Based) Containing 6 mg Ivermectin (REVECTINA®, Abbott Laboratórios do Brasil Ltda, Brazil) Bioequivalence Study of Albendazole 400 mg Tablets in Chinese Population Study of the Efficacy of Oxfendazole Compared to Albendazole in the Treatment of Trichuris Trichiura Infection in Adults Urine Albendazole Levels for Coverage Assessment Comparison of Immune Response in Normal Volunteers and Patients With Helminth Infections Empiric Therapy of Helminth Co-infection to Reduce HIV-1 Disease Progression An Evaluation of a Novel Food Product in Adults Residing in an Area Endemic for Helminths Relative Efficacy of Two Regimens of Ante-helminthic Treatment Can Presumptive Anthelminthic Treatment Delay the Progression of HIV in ART-naïve Patients in Rural Africa? Assessment of Drug Efficacy of Local Albendazole Study to Evaluate Efficacy and Safety of a Double Treatment Plan Using a Combination of Mebendazole and Quinfamide for Treating Intestinal Helminthiasis and Amebiasis in the Mexican Population